Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Small Cell Lung Carcinoma 8 Breast Neoplasms 8 Triple Negative Breast Neoplasms 7 Neoplasm Metastasis 4 Carcinoma, Non-Small-Cell Lung 4 Urinary Bladder Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Osteosarcoma 2 Lung Neoplasms 2 Uterine Cervical Neoplasms 1 Sarcoma, Ewing 1 Pathologic Complete Response 1 Neutropenia 1 Neoplasms 1 NSCLC 1 Myelosuppression 1 Limited Stage Small Cell Lung Cancer 1 Hemangiosarcoma 1 Head and Neck Neoplasms 1 Esophageal Neoplasms 1 Endometrial Neoplasms 1 Colorectal Neoplasms 1 Carcinoma, Transitional Cell 1 Advanced Squamous Non-Small-Cell Lung Cancer 1

Interventions

Cisplatin 252 Radiotherapy 176 Cetuximab 144 pembrolizumab 120 Docetaxel 96 Fluorouracil 92 Carboplatin 80 Paclitaxel 77 Radiotherapy, Intensity-Modulated 69 Nivolumab 37 Radiation 30 Drug Therapy 30 Erlotinib Hydrochloride 26 Gemcitabine 25 Gefitinib 21 Cyclophosphamide 21 Surveys and Questionnaires 20 Surgical Procedures, Operative 19 Standard of Care 19 Pemetrexed 19 durvalumab 18 Magnetic Resonance Spectroscopy 17 Capecitabine 17 Radiosurgery 16 Celecoxib 16 atezolizumab 15 Filgrastim 15 Amifostine 15 Low-Level Light Therapy 14 Everolimus 14

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Head and Neck Neoplasms × trilaciclib × Clear all

NCT06752798 2024-12-31

CCRT，LA-HNSCC

Hunan Cancer Hospital

Phase 2 Recruiting

Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡